CDH1 and prostate cancer: In the realm of breast and prostate cancer research, pioneering observations revealed CDH1 promoter CGI hypermethylation in invasive variants lacking E‐cadherin expression, with subsequent studies validating these findings across diverse tumor types.150, 151